Session 993: Predictive molecular pathology

Date: 3 February 2004, Time: 11:30 - 13:30
Location: Room 3

Oral Presentations

Time	Number	Title / Authors / Affiliations
11:30	26	Lung cancer and thyroid hormones: Primary hypothyroidism is prognostically significant for survival. A Hercbergs MD, J Mason MD MPH, C Reddy MS, P Elson DSc Cleveland Clinic Foundation, Cleveland, OH, United States
11:50	27	Cyclooxygenase-1 is upregulated in squamous cell carcinoma of the head and neck BM Erovic MD^a, S Kandutsch MD^b, M Woegerbauer MS^f, F Frommlet PhD^c, E Selzer MD^d, GV Kornek MD^e, C Neuchrist MD^a, MC Grasl MD^a, D Thurnher MD^a Departments of (a)Otorhinolaryngology, Head and Neck Surgery, (b)Clinical Pathology, (c)Medical Statistics, (d)Radiotherapy and Biology, and (e)Internal Medicine, Division of Oncology, University of Vienna Medical School, Austria; (f)Department of Research and Development, Birkmayer Laboratories.
12:05	28	Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas A Kovács MD^a, J Dhillon MD^b, RA Walker MD^b ^aDept. of Pathology, Gothenburg University, Gothenburg, Sweden, ^bBreast Cancer Research Unit, University of Leicester, Leicester, United Kingdom
12:20	29	Conventional clinical markers are by no means outperformed by microarray gene expression profilers in breast cancer prognosis P Edén PhD^a, C Ritz MSc^a, C Rose MD^b, M Fernö PhD^b, C Peterson PhD^a ^aComplex Systems Division, Department of Theoretical Physics, ^bDepartment of Oncology; Lund University, Lund, Sweden
12:35	30	Epstein-Barr virus infection in urothelal transitional cell carcinoma tissues as demonstrated by the presence of EBV-encoded RNA and its possible implications in the pathogenesis of this malignancy S-K Liao PhD^a, C-K Chuang MD PhD^a,b, M-J Liu BSc^b, T-R Chang BSc^a ^aGraduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan 333, Taiwan, ^bDivision of Urology, Department of Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan
12:50	31	Elevated CEA Prior to Complete Tumour Removal in Patients with Pseudomyxoma Peritonei Indicate an Increased Risk of Recurrence F Alexander-Sefre MRCOG FRCS, K Chandrakumaran FRCS, S Banerjee FRCS, T Cecil FRCS, BJ Moran PhD FRCS Pseudomyxoma Peritonei Centre, North Hampshire Hospital Basingstoke, UK